Lys-Nε-SPDB-DM4 is a cleavable drug-linker conjugate used to construct antibody-drug conjugates (ADCs) for targeted cancer therapy. It enables the delivery of the potent antimitotic agent DM4 to specific cells, facilitating research in both in vitro cytotoxicity assays and in vivo tumor model studies.